NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway

NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway

ABSTRACT Background Non‐small cell lung cancer (NSCLC) is a leading cause of cancer‐related deaths worldwide, and cisplatin (DDP) resistance remains a significant challenge in NSCLC treatment. Methods Quantitative reverse transcription polymerase chain reaction (qRT‐PCR) was used to analyze NAT10 an...

Full description

Saved in:
Bibliographic Details
Main Authors: Qi Sun, Xiansong Yang, Ye Wang, Kejia Yang, Yuan Weng
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Thoracic Cancer
Subjects:
DDP
NAT10
non‐small cell lung cancer
PI3K/AKT pathway
TRIM44
Online Access:https://doi.org/10.1111/1759-7714.70079
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items